Annual Drug Patent Expirations for VYVANSE Vyvanse is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from one supplier. There are eighteen…
The post New patent for Takeda Pharms drug VYVANSE appeared first on DrugPate…
Annual Drug Patent Expirations for REYVOW Reyvow is a drug marketed by Eli Lilly And Co and is included in one NDA. It is available from one supplier. There are…
The post New patent for Eli Lilly drug REYVOW appeared first on DrugPatentWatch – Make Bet…
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are six…
The post New patent for Abbvie Inc drug ORIAHNN (COPACKAGED)…
New patent for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
Annual Drug Patent Expirations for LUMIFY Lumify is a drug marketed by Bausch And Lomb Inc and is included in one NDA. It is available from one supplier. There is…
The post New patent for Bausch And drug LUMIFY appeared first on DrugPatentWatch – Make …
This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug patent…
Which pharmaceutical companies have the most drug patents in Spain? Read Post »
Annual Drug Patent Expirations for ZYVOX Zyvox is a drug marketed by Pfizer and is included in three NDAs. It is available from four suppliers. There are two patents protecting…
The post New patent expiration for Pfizer drug ZYVOX appeared first on Dru…
Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
Pharmaceutical companies with the most orphan drugs Read Post »
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPatentW…
This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2016 to 2021. Companies that successfully challenge patents on branded drugs are granted six…
The post Most prolific drug patent challengers …
Annual Drug Patent Expirations for XIIDRA Xiidra is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting…
The post New patent for Novartis drug XIIDRA appeared first on DrugPat…
Get new actionable insights and updates from BiotechBlog
